Literature DB >> 8592078

Proopiomelanocortin, its derived peptides, and the skin.

M Wintzen1, B A Gilchrest.   

Abstract

Proopiomelanocortin (POMC) is a protein synthesized predominately in the pituitary gland but also in a variety of other tissues, including the skin. Through enzyme-mediated cleavage that varies among cell types, POMC can give rise to at least eight distinct peptides whose biologic roles are incompletely delineated. Although blood-borne pituitary-derived bioactivity for the skin was first recognized 80 years ago and the responsible neuropeptides isolated 20-40 years ago, our understanding of POMC-derived peptides in skin is still rapidly evolving. In particular, recent work in cultured human and murine skin-derived cells has demonstrated POMC gene expression as well as modulation of POMC and many of its derived peptides in response to physiologic signals including ultraviolet irradiation and cytokines. Immunoreactivity for these peptides has also been detected in normal skin and hair follicles, strongly suggesting cutaneous synthesis in vivo. Candidate autocrine or paracrine functions include enhanced melanogenesis, immunomodulation, and effects on cell cycle regulation and differentiated function in both the epidermis and its appendages. This article reviews recent data concerning POMC gene expression and regulation, protein processing, signal transduction, and biologic functions relevant to cutaneous biology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8592078     DOI: 10.1111/1523-1747.ep12326950

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

Review 1.  "Sebocytes' makeup": novel mechanisms and concepts in the physiology of the human sebaceous glands.

Authors:  Balázs I Tóth; Attila Oláh; Attila G Szöllosi; Gabriella Czifra; Tamás Bíró
Journal:  Pflugers Arch       Date:  2011-03-08       Impact factor: 3.657

2.  Genetic studies of the mouse mutations mahogany and mahoganoid.

Authors:  K A Miller; T M Gunn; M M Carrasquillo; M L Lamoreux; D B Galbraith; G S Barsh
Journal:  Genetics       Date:  1997-08       Impact factor: 4.562

3.  Alpha-MSH regulates protein ubiquitination in T cells.

Authors:  D J Biros; K Namba; A W Taylor
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2006-05-30       Impact factor: 1.770

4.  Melanocyte-stimulating hormone directly enhances UV-Induced DNA repair in keratinocytes by a xeroderma pigmentosum group A-dependent mechanism.

Authors:  Liang Dong; Ji Wen; Eric Pier; Xiao Zhang; Bo Zhang; Fangzheng Dong; Nick Ziegler; Margaret Mysz; Rafael Armenta; Rutao Cui
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

Review 5.  Differential expression of HPA axis homolog in the skin.

Authors:  Andrzej Slominski; Jacobo Wortsman; Robert C Tuckey; Ralf Paus
Journal:  Mol Cell Endocrinol       Date:  2006-12-29       Impact factor: 4.102

6.  Skin function and skin disorders in Parkinson's disease.

Authors:  M Fischer; I Gemende; W C Marsch; P A Fischer
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

7.  Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.

Authors:  M T Bastiaens; J A ter Huurne; C Kielich; N A Gruis; R G Westendorp; B J Vermeer; J N Bavinck
Journal:  Am J Hum Genet       Date:  2001-03-16       Impact factor: 11.025

8.  Barrier requirements as the evolutionary "driver" of epidermal pigmentation in humans.

Authors:  Peter M Elias; Gopinathan Menon; Bruce K Wetzel; John Jack W Williams
Journal:  Am J Hum Biol       Date:  2010 Jul-Aug       Impact factor: 1.937

Review 9.  Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Cezary Skobowiat; Blazej Zbytek; Radomir M Slominski; Jeffery D Steketee
Journal:  Adv Anat Embryol Cell Biol       Date:  2012       Impact factor: 1.231

10.  Crucial role of the melanocortin receptor MC1R in experimental colitis.

Authors:  C Maaser; K Kannengiesser; C Specht; A Lügering; T Brzoska; T A Luger; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.